Format

Send to

Choose Destination
See comment in PubMed Commons below
Cardiol Clin. 2008 Nov;26(4):527-35. doi: 10.1016/j.ccl.2008.06.003.

Renin inhibitors: novel agents for renoprotection or a better angiotensin receptor blocker for blood pressure lowering?

Author information

1
Department of Hypertension and Nephrology, Dante Pazzanese Institute of Cardiology, Av. Dr. Dante Pazzanese, 500, Sao Paulo, SP, Brazil. espimenta@hotmail.com

Abstract

Aliskiren, the first in a new class of orally effective direct renin inhibitors (DRIs) was recently approved for the treatment of hypertension. In this review, we discuss the history of the development of DRIs and available data regarding the effects of DRIs in the treatment of hypertension and related target organ damage.

PMID:
18929229
DOI:
10.1016/j.ccl.2008.06.003
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center